Author Archives: Guest Writer

UN 5th High Level Meeting on HIV/AIDS: Civil society says “Yes — AND” to the 2021 political declaration

By on .

The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to approve the 2021 Political Declaration on HIV and AIDS introduced as part of the now fifth High Level Meeting on HIV/AIDS. Previous Declarations were accepted by unanimous consent, following […]

U = U: The evidence is in. Spreading the word that undetectable = untransmissable is the next crucial step

By on .

By Murray Penner of Prevention Access Campaign Undetectable = Untransmittable, or U=U, is a clear, effective, simple way to convey the fact that a person living with HIV who is on antiretroviral therapy and whose virus is suppressed cannot transmit HIV to sexual partners. In 2016, Prevention Access Campaign, a health equity initiative with the […]

Can unprecedented success in COVID vaccine development boost prospects for an HIV vaccine?

By on .

By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN 702, or Uhambo, was halted for lack of efficacy. Researchers and advocates had high hopes for Uhambo, building as it did on the RV144 trial, which provided the first […]

How do I know which adolescent girls are at greatest risk for HIV?

By on .

Innovative approaches can help find vulnerable young women in need of HIV prevention services The following is a guest post by Michelle Li, MS, and Quinn Lewis, MIA, of Data.FI project In sub-Saharan Africa, adolescent girls and young women are disproportionately impacted by HIV and are more likely to become infected, compared to their male […]

It’s a puzzle, it’s an algorithm, it’s deduplication

By on .

The following is a guest post by Richard Ngethe, MBA,  and Jonathan Friedman, MS According to a study by UNAIDS of Brazil, of an estimated 140 million records in the national user database—including all health records—only 100 million unique patients were represented. The number of patients, therefore, was overstated by 40%.[1] This is the kind […]

Four recommendations can move Indonesia toward achieving HIV epidemic control

By on .

The following is a guest post by Cathy Cantelmo, Rebecca Ross, Shree Prabhakaran and Arin Dutta Indonesia has not yet achieved UNAIDS 90-90-90 HIV treatment targets or epidemic control. Of the people living with HIV as of June 2020, only 63 percent knew their status, just a quarter were on antiretroviral therapy, and a mere […]

A plan maintains continuity of HIV care in a Nigerian state during COVID-19 lockdown

By on .

The following is a guest post by Tyra Fom of Data.FI The COVID-19 pandemic poses a double threat for people living with HIV, who must find ways during lockdown to access their antiretroviral therapy from overwhelmed health facilities. In addition, people who have the virus but are not yet diagnosed face challenges getting tested and […]

Training advances benefits of HIV data

By on .

The following is a guest post by Serge Bisore, MPH and Hypax Mbanye, MA, of Data.FI Using data to improve performance is challenging when the quality of the data is uneven. As we move towards epidemic control, national AIDS control programs and ministries of health need complete, timely, and accurate information on HIV indicators so […]

Science, not politics, must lead to COVID vaccine approvals

By on .

Political pressure to speed the introduction of COVID vaccines threatens scientifically proven systems to protect public safety and research integrity The following is a guest post from Uché Blackstock, MD, Founder & CEO, Advancing Health Equity, and Mitchell Warren, Executive Director, AVAC COVID-19 has devastated communities and health systems around the world – but it […]